CSTL vs TECH · rev $332.1M vs P/E 65, rev $1.22B
Castle Biosciences Inc (CSTL) versus Bio-Techne Corp (TECH) — a side-by-side from cached financials, not a winner call.
Castle Biosciences Inc (CSTL) is a diagnostics & research company listed on US.
Bio-Techne Corp (TECH) is a biotechnology company listed on US.
Latest reported CSTL revenue for 2024-12-31 was $332.1M. Net income was $18.2M. Revenue was up 51.1% from 2023-12-31 to 2024-12-31. CSTL currently screens at market cap $570.2M.
Latest reported TECH revenue for 2025-06-30 was $1.22B. Net income was $73.4M. Revenue was up 5.2% from 2024-06-30 to 2025-06-30. TECH currently screens at market cap $8.49B and trailing P/E 65.2.
CSTL currently screens at market cap $570.2M. TECH currently screens at market cap $8.49B and trailing P/E 65.2.
Not investment advice. Open the CSTL and TECH stock pages for the full models.
Not investment advice.